Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ResMed Inc.

    NYSE: RMD · Real-Time Price · USD
    251.37
    2.03 (0.81%)
    At close: Jun 16, 2025, 3:59 PM
    250.06
    -0.52%
    After-hours: Jun 16, 2025, 07:40 PM EDT

    ResMed Statistics

    Share Statistics

    ResMed has 146.63M shares outstanding. The number of shares has increased by -0.03% in one year.

    Shares Outstanding

    n/a
    		 146.63M

    Shares Change (YoY)

    n/a
    		 -0.03%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 61.32%

    Shares Floating

    n/a
    		 145.59M

    Failed to Deliver (FTD) Shares

    n/a
    		 883

    FTD / Avg. Volume

    n/a
    		 0.09%

    Short Selling Information

    The latest short interest is 10.59M, so 7.22% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.59M

    Short % of Shares Out

    n/a
    		 7.22%

    Short % of Float

    n/a
    		 8.31%

    Short Ratio (days to cover)

    n/a
    		 12.73

    Valuation Ratios

    The PE ratio is 26.92 and the forward PE ratio is 23.57. ResMed's PEG ratio is 2.01.

    PE Ratio

    n/a
    		 26.92

    Forward PE

    n/a
    		 23.57

    PS Ratio

    n/a
    		 5.87

    Forward PS

    n/a
    		 5.3

    PB Ratio

    n/a
    		 5.65

    P/FCF Ratio

    n/a
    		 21.37

    PEG Ratio

    n/a
    		 2.01
    Financial Ratio History

    Enterprise Valuation

    ResMed has an Enterprise Value (EV) of 28.12B.

    EV / Sales

    n/a
    		 6

    EV / EBITDA

    n/a
    		 18.34

    EV / EBIT

    n/a
    		 20.07

    EV / FCF

    n/a
    		 21.86

    Financial Position

    The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 2.59

    Quick Ratio

    n/a
    		 1.69

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 0.57

    Debt / FCF

    n/a
    		 0.68

    Interest Coverage

    n/a
    		 28.88

    Financial Efficiency

    Return on Equity is 20.99% and Return on Invested Capital is 17.69%.

    Return on Equity

    n/a
    		 20.99%

    Return on Assets

    n/a
    		 14.86%

    Return on Invested Capital

    n/a
    		 17.69%

    Revenue Per Employee

    n/a
    		 $469,468.64

    Profits Per Employee

    n/a
    		 $102,299.7

    Employee Count

    n/a
    		 9,980

    Asset Turnover

    n/a
    		 0.68

    Inventory Turnover

    n/a
    		 2.47

    Taxes

    Income Tax

    n/a
    		 243.85M

    Effective Tax Rate

    n/a
    		 19.28%

    Stock Price Statistics

    The stock price has increased by 19.5% in the last 52 weeks. The beta is 0.77, so ResMed's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.77

    52-Week Price Change

    n/a
    		 19.5%

    50-Day Moving Average

    n/a
    		 236.77

    200-Day Moving Average

    n/a
    		 237.84

    Relative Strength Index (RSI)

    n/a
    		 60.46

    Average Volume (20 Days)

    n/a
    		 1,021,849

    Income Statement

    In the last 12 months, ResMed had revenue of 4.69B and earned 1.02B in profits. Earnings per share was 6.94.

    Revenue

    n/a
    		 4.69B

    Gross Profit

    n/a
    		 2.66B

    Operating Income

    n/a
    		 1.32B

    Net Income

    n/a
    		 1.02B

    EBITDA

    n/a
    		 1.53B

    EBIT

    n/a
    		 1.31B

    Earnings Per Share (EPS)

    n/a
    		 6.94
    Full Income Statement

    Balance Sheet

    The company has 238.36M in cash and 873.93M in debt, giving a net cash position of -635.57M.

    Cash & Cash Equivalents

    n/a
    		 238.36M

    Total Debt

    n/a
    		 873.93M

    Net Cash

    n/a
    		 -635.57M

    Retained Earnings

    n/a
    		 4.99B

    Total Assets

    n/a
    		 7.57B

    Working Capital

    n/a
    		 2.27B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.4B and capital expenditures -114.86M, giving a free cash flow of 1.29B.

    Operating Cash Flow

    n/a
    		 1.4B

    Capital Expenditures

    n/a
    		 -114.86M

    Free Cash Flow

    n/a
    		 1.29B

    FCF Per Share

    n/a
    		 8.75
    Full Cash Flow Statement

    Margins

    Gross margin is 56.67%, with operating and profit margins of 28.17% and 21.79%.

    Gross Margin

    n/a
    		 56.67%

    Operating Margin

    n/a
    		 28.17%

    Pretax Margin

    n/a
    		 27%

    Profit Margin

    n/a
    		 21.79%

    EBITDA Margin

    n/a
    		 32.73%

    EBIT Margin

    n/a
    		 28.17%

    FCF Margin

    n/a
    		 27.46%

    Dividends & Yields

    RMD pays an annual dividend of $2.6, which amounts to a dividend yield of 0.87%.

    Dividend Per Share

    n/a
    		 $2.60

    Dividend Yield

    n/a
    		 0.87%

    Dividend Growth (YoY)

    n/a
    		 10.42%

    Payout Ratio

    n/a
    		 28.99%

    Earnings Yield

    n/a
    		 3.71%

    FCF Yield

    n/a
    		 4.68%
    Dividend Details

    Analyst Forecast

    The average price target for RMD is $272, which is 8.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $272

    Price Target Difference

    n/a
    		 8.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $69.4

    Lynch Upside

    n/a
    		 -72.39%

    Graham Number

    n/a
    		 71.9

    Graham Upside

    n/a
    		 -71.4%

    Stock Splits

    The last stock split was on Aug 31, 2010. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Aug 31, 2010

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 13.77

    Piotroski F-Score

    n/a
    		 9

    Add to Watchlist